Long-term intravenous administration of carboxylated single-walled carbon nanotubes induces persistent accumulation in the lungs and pulmonary fibrosis via the nuclear factor-kappa B pathway [Corrigendum]
Authors Qin Y, Li S, Zhao G, Fu X, Xie X, Huang Y, Cheng X, Wei J, Liu H, Lai Z
Received 25 January 2016
Accepted for publication 25 January 2016
Published 23 February 2017 Volume 2017:12 Pages 1515—1516
Yue Qin, Suning Li, Gan Zhao, et al. Int J Nanomedicine. 2017;12:263–277.
Page 266. In the right column the data range “6 to 15 nm” should be “5 to 15 nm”.
Page 267. In Figure 1 Notes “wt%” should be “wt‰ in SWNTs powder”.
Page 268. In Figure 2 Notes “1 mL per rat” should be “1 mL/kg body weight”.
Read the original article.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]